EN
HI

Biocon Share price

BIOCON

349

1.20 (0.35%)
NSE
BSE
Last updated on 8 Oct, 2025 | 15:56 IST
BUYSELL
Today's High

354.95

Today's Low

346.90

52 Week Low

291.00

52 Week High

406.00

The current prices are delayed, login to your account for live prices

Biocon Share Key Metrics

Volume
35.03 L
Market Cap
46660.03 CR
LTQ@LTP
1@349.00
ATP
350.59
Var Margin
16.82 %
Circuit Range
313.05-382.55
Delivery %
55.05 %
Value
122.82 CR
ASM/GSM
No
Market Lot
1

Biocon Fundamentals

View More
P/E Ratio

120.86

P/B Ratio

1.8

Div. Yield

0.14

Sector P/E

37.73

Sector P/B

3.6

Sec. Div. Yield

0.55

Biocon Resistance and Support

Pivot 347.52

Resistance

First Resistance

352.04

Second Resistance

355.47

Third Resistance

359.99

Support

First Support

344.09

Second Support

339.57

Third Support

336.14

Biocon Futures & Options

BIOCON-EQ

349

1.2 (0.35%)

Biocon Option Chain

View Price, OI, Greeks & More...
View All

28OCT25

350.00

0.00 (0.00%)

25NOV25

352.05

0.05 (0.01%)

30DEC25

354.60

0.80 (0.23%)

BIOCON|28OCT25 CE 345.00

11.20

0.1 (0.9%)

BIOCON|28OCT25 PE 350.00

8.1

-0.1 (-1.22%)

Biocon Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

54.45%

Mutual Fund

15.24%

Insurance

6.79%

Foreign Institutional Investors

6.04%

Domestic Institutional Investors

0.79%

Retail

16.68%

Others

0.01%

Total Promoters
MAR '25
60.64%
JUN '25
54.45%

Biocon Corporate Actions

DateAgenda
2025-11-11Quarterly Results
2025-10-01Redemption (Part) of NCD
2025-08-07Quarterly Results
2025-05-08Audited Results & Final Dividend
2025-04-23Others
2025-04-04To consider Fund Raising
2025-01-30Quarterly Results & Others
2025-01-27Others

Biocon News

Biocon Biologics gets US nod to launch Stelara biosimilar

Dec 02 2024 05:37:06

Biocon Biologics looks to trim $300 million debt in 1 year

Nov 19 2024 16:56:57

Biocon shares surge 5% after USFDA classifies Bengaluru site as VAI

Nov 11 2024 10:16:59

Biocon shares surge 5% after USFDA clears Bengaluru unit as VAI

Nov 11 2024 09:56:52
Read More

About Biocon AboutThe

NSE : 11373  
BSE : 532523  
ISIN : INE376G01013  

HISTORY AND CERTAIN CORPORATE MATTERSOur Company was incorporated as Biocon India Private Limited onNovember 29 1978 under the Companies Act. The word `Private' wasdeleted from our name under the provisions of Section 43A(2) of theCompanies Act with effect from July 1 1995. Thereafter our Company wasconverted to a private limited company under the provisions of Section43(2A) of the Companies Act with effect from December 21 2000. It wasreconverted into a public limited company on June 18 2001. The name ofour Company was changed from Biocon India Limited to Biocon Limited anda fresh certificate of incorporation consequent on change of name wasissued by the RoC on November 19 2003.Our Corporate StructureOur existing corporate structure is as under:Biocon LimitedClinigene International PrivateLimited (100.00%)Biocon Biopharmaceuticals PrivateLimited (51.00%)Syngene International PrivateLimited (99.99%)Interest of Promoters Directors and Key Managerial PersonnelExcept as stated in ?Related Party Transactions? on page 84 of this RedHerring Prospectus and to the extent of shareholding in our Companythe Promoters do not have any other interest in our business.Our Promoters have significant rights in our Company under the terms ofour Articles of Association. For additional information please referto the section entitled ?Main Provisions of Articles of Association ofBiocon Limited? on page 168 of this Red Herring Prospectus.Except to the extent of their compensation and to the extent of ESOPif any as mentioned on page 165 of this Red Herring Prospectus andtheir shareholding or shareholding of companies they represent theDirectors other than Promoter Directors do not have any otherinterest in our Company. Our Director Mr. John Shaw is the husband ofour Chairman & Managing Director Ms. Kiran Mazumdar-Shaw. OurDirector Prof. Ravi Mazumdar is the brother of our Chairman & ManagingDirector Ms. Kiran Mazumdar-Shaw. Our alternate Director Prof.Catherine Rosenberg is the sister-in-law of our Chairman & ManagingDirector Ms. Kiran Mazumdar-Shaw.The key managerial personnel of our Company do not have any interest inour Company other than to the extent of the remuneration or benefits towhich they are entitled to as per their terms of appointment andreimbursement of expenses incurred by them during the ordinary courseof business and to the extent of the Equity Shares held by them in theCompany if any and options granted to them under the ESOP.

Read More

Biocon Management

NamePosition
Ms. Kiran Mazumdar Shaw Executive Chairperson
Mr. Siddharth Mittal Managing Director & CEO
View More

Biocon FAQs

Biocon शेयर का खरीद मूल्य 349 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Biocon शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Biocon शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 120.86 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Biocon शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 1.8 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Biocon शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.6 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Biocon का मार्केट कैप 46660.03 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Biocon शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 406.00 और 291.00 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।